Viewing Study NCT05193851


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-03-11 @ 7:36 AM
Study NCT ID: NCT05193851
Status: COMPLETED
Last Update Posted: 2023-04-03
First Post: 2021-12-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety and Pharmacokinetics of Ricolinostat
Sponsor: Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module